Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Morse Asset Management Inc lifted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 3,763 shares of the biopharmaceutical company’s stock after acquiring an additional 75 shares during the quarter. Morse Asset Management […]
LSV Asset Management cut its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.2% in the 1st quarter, Holdings Channel reports. The fund owned 49,400 shares of the biopharmaceutical company’s stock after selling 2,700 shares during the quarter. LSV Asset Management’s holdings in Regeneron Pharmaceuticals were worth $40,590,000 as of its […]
Yousif Capital Management LLC lowered its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,296 shares of the biopharmaceutical company’s stock after selling 728 shares during the quarter. Yousif Capital Management […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective decreased by Guggenheim from $935.00 to $900.00 in a research report sent to investors on Monday morning, FlyOnTheWall reports. Several other brokerages have also recently weighed in on REGN. Wells Fargo & Company lowered their price target on shares of Regeneron Pharmaceuticals from $915.00 to […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-one research firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, four have given a hold recommendation and sixteen have assigned a buy recommendation to the […]